Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country

Luis Rivera1, Xavier Sáez-Llorens2, Jesus Feris-Iglesias3

  • 1Hospital Maternidad Nuestra Señora de la Altagracia, Santo Domingo, Dominican Republic. lrp@claro.net.do.

BMC Pediatrics
|October 3, 2015
PubMed

Insights

Group B Streptococcus (GBS) infections pose a significant threat to newborns. This study reveals high early-onset GBS disease incidence in the Dominican Republic, emphasizing the need for prevention strategies in Latin America and Asia.

Area of Science:

  • Neonatal infections
  • Infectious disease epidemiology
  • Microbiology

Background:

  • Group B Streptococcus (GBS) is a major cause of severe neonatal infections globally.
  • Limited incidence data exists for GBS in Latin America and Asia.

Purpose of the Study:

  • To determine the incidence of GBS infections in infants across diverse Asian and Latin American settings.
  • To identify key GBS serotypes causing infant infections.
  • To inform public health strategies for GBS prevention.

Main Methods:

  • A multicenter, hospital-based observational study was conducted in Panama, Dominican Republic, Hong Kong, and Bangladesh.
  • Infants aged 0-89 days with GBS isolated from sterile sites were enrolled over 12 months.
  • Data on early-onset disease (EOD) and late-onset disease (LOD) were collected.

Main Results:

  • The incidence of EOD was highest in the Dominican Republic (2.35/1000 live births), lower in Hong Kong (0.76/1000) and Panama (0.77/1000).
  • No GBS cases were identified in Bangladesh.
  • Over 90% of EOD occurred on day 1 of life, with fatality rates varying from 6.7% to 40%.

Conclusions:

  • Dominican Republic's EOD incidence resembles pre-screening US rates; Hong Kong's is higher than previously reported Asian rates.
  • The absence of cases in Bangladesh suggests a need to investigate surveillance and healthcare factors.
  • High disease burden and specific serotypes (Ia, Ib, III) underscore the need for prevention and community-based surveillance.
Abstract

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
41
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.6K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.4K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
34
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
37